Simulations Plus, Inc.
Simulations Plus, Inc. (Nasdaq: SLP) is a global leader in providing advanced software and consulting services to the biopharmaceutical sector. The company's website is www.simulations-plus.com. Founded in 1996 and headquartered in Research Triangle Park, North Carolina, with a European office in Paris, France,… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Simulations Plus, Inc. does
In the company’s own words
Simulations Plus, Inc. (Nasdaq: SLP) is a global leader in providing advanced software and consulting services to the biopharmaceutical sector. The company's website is www.simulations-plus.com. Founded in 1996 and headquartered in Research Triangle Park, North Carolina, with a European office in Paris, France, Simulations Plus serves clients across the entire drug development lifecycle from early discovery through clinical research and commercialization.
The company operates through two primary business segments: software and services. Software represented 58 percent of total revenue during fiscal year 2025, while services accounted for 42 percent. The software portfolio includes discovery tools such as ADMET Predictor and MedChem Designer, development platforms including GastroPlus, DILIsym, and Thales, clinical operations solutions like Pro-ficiency, and commercialization tools including Panorama KOL Insights. The MonolixSuite represents a specialized modeling and simulation solution for pharmaceutical companies and biotechnology enterprises.
The services business encompasses model-informed drug development consulting, physiologically-based pharmacokinetic modeling, quantitative systems pharmacology, clinical pharmacology services, clinical operations training, and medical communications support. Simulations Plus leverages artificial intelligence and machine learning technologies across its product offerings to enhance drug discovery efficiency and reduce development timelines and costs.
The company's clients include major pharmaceutical and biotechnology companies, agrochemical firms, cosmetics manufacturers, food industry companies, universities, hospitals, and government research and regulatory agencies worldwide. As of August 31, 2025, Simulations Plus employed 213 people, with over 99 percent working full-time and more than 70 percent possessing life sciences software, services, and research and development backgrounds. More than 60 percent of technical and scientific staff hold advanced degrees in mathematics, chemistry, biomedical engineering, or pharmaceutical sciences.
Simulations Plus differentiates itself through proprietary databases of experimental results, extensive scientific expertise, collaborative relationships with pharmaceutical companies and academic institutions, and continuous investment in research and development. The company markets its offerings globally through scientific conferences, trade shows, seminars, online presentations, and independent distributors in Japan, China, India, South Korea, and Brazil.
Company details
- Sector
- Technology
- Industry
- Business Services & Software
- Headquarters
- DURHAM, NC
- Fiscal year end
- August
- CIK
- 1023459
- SIC
- 7373
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Simulations Plus, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Simulations Plus, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Simulations Plus, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Simulations Plus, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Simulations Plus, Inc.'s last four quarterly filings that the numbers alone won't show?”